Related Articles
Antiproliferative effects of imatinib mesylate on ZR‑75‑1 and MDA‑MB‑231 cell lines via PDGFR‑β, PDGF‑BB, c‑Kit and SCF expression Corrigendum in /10.3892/ijmm.2019.4119
Expression of stem cell factor in gastrointestinal stromal tumors: Implications for proliferation and imatinib resistance
Acquired resistance to imatinib and secondary KIT exon 13 mutation in gastrointestinal stromal tumour
Design, synthesis and preclinical evaluation of NRC-AN-019
RUNX1T1 is overexpressed in imatinib mesylate-resistant cells